Skip to the guide
Understanding care in North Carolina
Raleigh / Peptide CareChoosing between room and screen
Menu

Raleigh care guide · Made to order

What “compounded” changes

If the offer says “custom” or “compounded,” ask what the change is and how it matters to your care.

What the word means

Compounding means making a drug to meet a patient’s need, through a pharmacist, a doctor or a larger place that makes medicine.

The larger place makes batches of medicine and gives its details to FDA, the US drug-review agency, when it registers as an outsourcing facility.

FDA inspects these places and requires them to follow the quality rules used by drug factories.

That registration alone cannot show FDA approval for the medicine.

FDA says compounding can have a role if an approved medicine is unavailable or cannot meet a medical need.

One reason for a change is an allergy to a dye used in the finished medicine.

Ask what that need is. Then ask how the change would meet it. Get the name of the place that will make the drug.

The rules cover both ingredients and copies

As of September 2026, US law limited which raw drug ingredients a pharmacy could use to make medicine to order. An ingredient needed to meet an official quality standard for drugs, be part of an approved drug if no such standard existed, or be on FDA’s list of allowed ingredients if neither applied.

Federal law also limited making copies of available drugs often or in large amounts.

A changed medicine could be allowed under this copy rule if the person writing the prescription decided the change made an important difference for that particular patient. The other rules for making the medicine still applied.

A lower price did not count as that difference.

Ask the pharmacy which rule allows each drug ingredient. Ask the person writing your prescription what is being changed and how that change meets your medical need. A different colour or extra ingredient alone does not explain the reason for your care.

Weight-loss copies need a current explanation

As of September 2026, FDA’s national shortage list included neither semaglutide injections nor tirzepatide injections.

When these injections were in short supply, the shortage allowed pharmacies to make copies under special rules. By September 2026, that permission had ended. Pharmacies still had to meet the usual rules for making medicine to order, including limits on copies.

FDA said a drug may remain a copy even after a vitamin is added.

For a change to fall outside the copy rule, the person writing the prescription needed to record why it made an important difference for that patient.

Ask why the medicine can be made for your own medical need under the rules now. Have the person writing the prescription explain the reason.